Omid Hamid, MD | Authors

November 12, 2016

Omid Hamid, MD, chief, Translational Research and Immunotherapy, director, Melanoma Therapeutics, discusses current and emerging immunotherapeutic strategies in the field of melanoma during an interview at the 34th Annual Chemotherapy Foundation SymposiumTM.

March 12, 2016

Hamid says the future will hold adding more tolerable regimens in to the treatment paradigm of melanoma, based on the past success of the treatments already utilized and approved.

March 19, 2015

Omid Hamid, MD, discusses sequencing and combining targeted therapies in the treatment of melanoma.

November 05, 2013

Omid Hamid, MD, discusses promising combination therapies for the treatment of melanoma.